USP Disintegration apparatus as a potential tool for evaluating drug release from controlled-release dosage forms

Dissolution Technologies

Volumn 16, Issue 1, 2009, Pages 25-32

  Chuong, Monica C ^a   Lee, Ronald G ^a   Saxena, Vaibhav ^a   Palugan, Luca ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69349104744     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT160109P25     Document Type: Article

References (18)

1. Pernarowski, M.; Woo, W.; Searle, R. O. Continuous-flow apparatus for the determination of the dissolution characteristics of tablets and capsules. J. Pharm. Sci. 1968, 57 (8), 1419-1421.
2. Kramer, J.; Grady, L. T.; Gajendran, J. Historical Development of Dissolution Testing. In Pharmaceutical Dissolution Testing; Dressman, J. J, Kramer, J., Eds.; Taylor & Francis Group: New York, 2005; p 8.
3. Wong, G.; Collins, C. C. Dissolution Testing. In Preformulation in Solid Dosage Form Development; Adeyeye, M. C., Brittain, H. G., Eds.; Informa Healthcare USA Inc.: New York, 2008; pp 478-480.
4. Allen, L. V., Jr.; Popovich, N. G.; Ansel, H. C. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems, 8th ed.; Lippincott Williams and Wilkins: Philadelphia, 2004, p 237.
5. O'Neil, M. J.; Smith, A.; Heckelman, P. E.; Budavari, S. The Merck Index, 13th ed.; John Wiley & Sons, Inc.: Hoboken, NJ, 2001; pp 6552-6553.
6. Lemke, T. L.; Williams, D. A.; Roche, V. F.; Zito, S. W. Foye's Principles of Medicinal Chemistry, 6th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, 2008, p 1349.
7. Marks, J. W. Niacin. MedicineNet, Inc. Web site. urlhttp://www.medicinenet.com/niacin/article.htm (accessed Jan 15, 2009).
8. Tsang, G. The Myth of Calcium Supplements: Which One Is the Best?, 2004. HealthCastle Nutrition, Inc. Web site. urlhttp://www.healthcastle.com/calciumpill.shtml (accessed Jan 15, 2009).
9. Niacin Tablets. In United States Pharmacopeia and National Formulary USP 31-NF 26; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2008; pp 2799-2800.
10. Dissolution <711>. In United States Pharmacopeia and National Formulary USP 31-NF 26; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2008; pp 267-274.
11. Disintegration <701>. In United States Pharmacopeia and National Formulary USP 31-NF 26; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2008; pp 266-267.
12. Gibson, M. Pharmaceutical Preformulation and Formulation; Interpharm/CRC: Boca Raton, 2004; p 108.
13. Washington, N.; Washington, C.; Wilson, C. G. Physiological Pharmaceutics; Taylor and Francis: New York, 2001; p 149.
14. Avdeef, A. Physicochemical profiling (solubility, permeability and charge state). Curr. Topics Med. Chem. 2001, 1 (4), 277-351.
15. Buffer Solutions. In United States Pharmacopeia and National Formulary USP 31-NF 26; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2008; pp 813-814.
16. Gray, V. A. Compendial Testing Equipment: Calibration, Qualification, and Sources of Error. In Pharmaceutical Dissolution Testing; Dressman, J., Krämer, J., Eds.; Taylor & Francis Group, LLC: Boca Raton, FL, 2005;. p 43.
17. Klein, S.; Stippler E.; Wunderlich, M.; Dressman, J. Development of Dissolution Tests on the Basis of Gastrointestinal Physiology. In Pharmaceutical Dissolution Testing; Dressman, J., Krämer, J., Eds.; Taylor& Francis Group, LLC: Boca Raton, FL, 2005; p 215.
18. Zar, J. H. Biostatistical Analysis, 4th ed.; Prentice Hall: Upper Saddle River, NJ, 1999; pp 80-81.